Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (U01CA175315)
  • National Institute of General Medical Sciences, National Institutes of Health (R01GM113888)
  • 111 Project (B16047)
  • National key research and development program (2017YFE0109900)
  • National Cancer Institute (NCI P30CA093373)

This publication has 44 references indexed in Scilit: